We are live on ! Find out more
AVNS

Avanos Medical
AVNS

Delisted

AVNS was delisted on the 24th of July, 2026.

335 hedge funds and large institutions have $1.64B invested in Avanos Medical in 2017 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 91 increasing their positions, 116 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $1.54B → $1.64B (+$104M)

6% less call options, than puts

Call options by funds: $1.57M | Put options by funds: $1.67M

7% less funds holding

Funds holding: 360335 (-25)

22% less repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 116

33% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 51

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
335
Holders Change
-25
Holders Change %
-6.94%
% of All Funds
8.34%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
34
Increased
91
Reduced
116
Closed
51
Calls
$1.57M
Puts
$1.67M
Net Calls
-$100K
Net Calls Change
-$5.13M
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Advisers
126
Two Sigma Advisers
New York
$637K -$1.23M -31,559 -65%
OPERF
127
Oregon Public Employees Retirement Fund
Oregon
$621K +$7.79K +200 +1%
SG Americas Securities
128
SG Americas Securities
New York
$608K +$316K +8,122 +104%
OAM
129
Oppenheimer Asset Management
New York
$564K +$577K +14,806 New
Nisa Investment Advisors
130
Nisa Investment Advisors
Missouri
$553K -$14.8K -380 -3%
Tudor Investment Corp
131
Tudor Investment Corp
Connecticut
$546K +$237K +6,078 +74%
Capstone Investment Advisors
132
Capstone Investment Advisors
New York
$524K +$43.3K +1,110 +9%
GIA
133
Gateway Investment Advisers
Ohio
$515K
Bessemer Group
134
Bessemer Group
New Jersey
$505K -$11.7K -299 -2%
SEI Investments
135
SEI Investments
Pennsylvania
$503K +$19.6K +503 +4%
BNP Paribas Financial Markets
136
BNP Paribas Financial Markets
France
$482K -$283K -7,261 -36%
WCM
137
Wedge Capital Management
North Carolina
$479K +$490K +12,564 New
Citigroup
138
Citigroup
New York
$477K -$2.01M -51,592 -80%
ST
139
Somerset Trust
Pennsylvania
$477K +$485K +12,450 +15,962%
Verition Fund Management
140
Verition Fund Management
Connecticut
$474K +$178K +4,571 +58%
FHAM
141
Folger Hill Asset Management
New York
$473K -$5.07K -130 -1%
B
142
Barings
North Carolina
$464K +$238K +6,100 +100%
AW
143
Alpha Windward
Massachusetts
$455K -$39.7K -1,020 -8%
LSERS
144
Louisiana State Employees Retirement System
Louisiana
$449K +$11.7K +300 +3%
OA
145
Oak Associates
Ohio
$446K
CG
146
Caprock Group
Idaho
$421K -$40.8K -1,047 -9%
Commonwealth Equity Services
147
Commonwealth Equity Services
Massachusetts
$417K +$2.34K +60 +0.6%
LA
148
Lucus Advisors
New York
$409K +$419K +10,749 New
HSBC Holdings
149
HSBC Holdings
United Kingdom
$397K -$534K -13,716 -57%
PA
150
Profund Advisors
Maryland
$393K -$50.9K -1,306 -11%

AVNS Hedge Fund Activity: Q1 2017 in Review

335 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2017, worth a combined $1.64B — up 6.7% from $1.54B a quarter earlier.

Sellers outnumbered buyers: 51 funds closed out of AVNS and 34 opened new positions — a net loss of 17 holders — while 116 trimmed existing stakes and 91 added.

The largest buyer was BlackRock, adding an estimated $228M. The largest seller was Shapiro Capital Management, cutting an estimated $6.45M.

  • 335 institutional investors held Avanos Medical (AVNS) as of Q1 2017, down from 360 in Q4 2016.
  • Funds reported $1.64B of Avanos Medical stock for Q1 2017, up 6.7% quarter-over-quarter.
  • 34 funds opened new Avanos Medical positions in Q1 2017 and 51 closed out, a net change of -17 holders.
  • The largest Avanos Medical buyer in Q1 2017 was BlackRock, an estimated $228M added.
  • The largest Avanos Medical seller in Q1 2017 was Shapiro Capital Management, an estimated $6.45M sold.

Based on aggregated 13F filings for Q1 2017.